Lucinda H. Elliott

T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors

Lorri A. Morford, Lucinda H. Elliott, Sonia L. Carlson et al. · The Journal of Immunology · 1997 · 139 citations

Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.

Lucinda H. Elliott, William H. Brooks, Thomas L. Roszman · The Journal of Immunology · 1984 · 105 citations · Full text

Cytokinetic Basis, Immunology, Immunoediting +20

Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas

Lucinda H. Elliott, William H. Brooks, Thomas L. Roszman · Journal of neurosurgery · 1987 · 66 citations

Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors.

Lucinda H. Elliott, William H. Brooks, Thomas L. Roszman · Journal of Clinical Investigation · 1990 · 60 citations · Full text

Brain Tumor Patients, T-regulatory Cell, Immunology +18

Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas.

Lucinda H. Elliott, William H. Brooks, Thomas L. Roszman · PubMed · 1987 · 58 citations

Immunology, Cell Death, Immunologic Mechanism +19